Mefanamic acid

Get a Price/Quote

Product Details:

Shelf Life 5 Years
Molecular Weight 241.285 g/mol
Molecular Formula C15H15NO2
Storage Keep away from moisture
Chemical Name Mefanamic acid
CAS No 61-68-7
Type Other
Click to view more
Share Your Product:

Ask A Question Send Inquiry

Product Details
Product Description

Product Specifications

Chemical Name Mefanamic acid
CAS No 61-68-7
Storage Keep away from moisture
Shelf Life 5 Years
Type Other
Molecular Formula C15H15NO2
Physical Form Powder
Molecular Weight 241.285 g/mol
Grade Medicine Grade
Usage anti-inflammatory drug

Trade Information

FOB Port Sahar Air/Nhava Sheva/Hazira
Payment Terms Telegraphic Transfer (T/T), Letter of Credit at Sight (Sight L/C), Cash in Advance (CID), Cash Advance (CA)
Delivery Time 2-3 Week
Sample Available Yes
Sample Policy Free samples available with shipping and taxes paid by the buyer
Packaging Details 25 kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum.
Main Export Market(s) Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia
Main Domestic Market All India
Certifications WHO, GMP, COA, MSDS, As Per Clients Requirement

Product Description

Product Name : Mefanamic acid

Grade : IP / BP / USP

Therapeutic Category : NSAID

CAS No : 61-68-7

Mefenamic acid is a non-steroidal anti-inflammatory drug used to treat pain, including menstrual pain. It is typically prescribed for oral administration.

Mefenamic acid decreases inflammation (swelling) and uterine contractions by a still unknown mechanism. However it is thought to be related to the inhibition of prostaglandin synthesis. There is also evidence that supports the use of mefenamic acid for perimenstrual migraine headache prophylaxis, with treatment starting 2 days prior to the onset of flow or 1 day prior to the expected onset of the headache and continuing for the duration of menstruation.

Since hepatic metabolism plays a significant role in mefenamic acid elimination, patients with known liverdeficiency may be prescribed lower doses. Kidney deficiency may also cause accumulation of the drug and its metabolites in the excretory system. Therefore patients suffering from renal conditions should not be prescribed mefenamic acid.

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

North & South America: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, etc .

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.

Tags

Mefanamic acid Manufacturers India,Mefanamic acid suppliers India,Mefanamic acid Exporters India,Mefanamic acid Powder Manufacturer India,Mefanamic acid Powder Supplier India,Mefanamic acid API Manufacturer India,Mefanamic acid API Suppliers India,Buy Mefanamic acid Online India,Mefanamic acid Price,Mefanamic acid Bulk Drugs Manufacturer India,Mefanamic acid